Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 4,778 shares at $17.24 ($88K) on 2018-10-02, disclosed to the SEC on 2018-10-04.
Scheduled sale ($88k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.24 | 1,433 | $25K | 28.2% |
| 2 | $19.23 | 1,500 | $29K | 32.9% |
| 3 | $18.43 | 1,845 | $34K | 38.8% |
| Total | $18.32 avg | 4,778 | $88K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |